Journal Mobile Options
Table of Contents
Vol. 11, No. 1-2, 2006
Issue release date: July 2006

Diagnosis of Paroxysmal Nocturnal Hemoglobinuria by Fluorescent Clostridium septicum Alpha Toxin

Shin D.-J. · Cho D. · Kim Y.R. · Rhee J.H. · Choy H.E. · Lee J.-J. · Hong Y.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Paroxysmal nocturnal hemoglobinuria (PNH), a hematopoietic stem cell disorder, is caused by the loss of glycosylphosphatidylinositol (GPI)-anchored proteins on the cell membrane. PNH can be simply diagnosed by flow cytometry using monoclonal antibodies against GPI-anchored proteins or fluorescent-tagged aerolysin, a bacterial toxin that binds GPI anchored proteins. Clostridium septicum alpha toxin is homologous to aerolysin and specifically binds GPI-anchored proteins. Previously, we found that an alpha toxin m45 mutant with two amino acid changes, S189C/S238C, lost cytotoxicity but still possessed binding activity for GPI-anchored proteins. To use this mutant toxin as a diagnostic probe in flow cytometry, we constructed the EGFP-AT(m45) expression vector, comprising a S189C/S238C alpha toxin mutant with EGFP and His tags at the N and C termini, respectively. The recombinant EGFP-AT(m45) was easily purified using single-step affinity chromatography against His tag from Escherichia coli. EGFP-AT(m45) bound to CHO and HeLa cells in a similar manner to monoclonal antibodies against GPI-anchored proteins or aerolysin. In whole blood from a PNH patient, GPI-deficient granulocytes could be differentiated by EGFP-AT(m45) using the same procedure as that employed with commercially available monoclonal antibodies. Therefore, nontoxic EGFP-conjugated C. septicum alpha toxin could be used clinically for PNH diagnosis.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Abrami L, Fivaz M, Glauser PE, Parton RG, van der Goot FG: A pore-forming toxin interacts with a GPI-anchored protein and causes vacuolation of the endoplasmic reticulum. J Cell Biol 1998;140:525–540.
  2. Ballard J, Crabtree J, Roe BA, Tweten RK: The primary structure of Clostridium septicum alpha-toxin exhibits similarity with that of Aeromonas hydrophila aerolysin. Infect Immun 1995;63:340–344.
  3. Brodsky RA, Mukhina GL, Li S, Nelson KL, Chiurazzi PL, Buckley JT, Borowitz MJ: Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol 2000;114:459–466.
  4. Dunn DE, Tanawattanacharoen P, Boccuni P, Nagakura S, Green SW, Kirby MR, Kumar MS, Rosenfeld S, Young NS: Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med 1999;131:401–408.
  5. Ferguson MA: The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J Cell Sci 1999;112:2799–2809.
  6. Figueroa-Arredondo P, Heuser JE, Akopyants NS, Morisaki JH, Giono-Cerezo S, Enriquez-Rincon F, Berg DE: Cell vacuolation caused by Vibrio cholerae hemolysin. Infect Immun 2001;69:1613–1624.
  7. Fivaz M, Abrami L, Tsitrin Y, van der Goot FG: Aerolysin from Aeromonas hydrophila and related toxins. Curr Top Microbiol Immunol 2001;257:35–52.
  8. Garcia-Silva MT, Matthijs G, Schollen E, Cabrera JC, Sanchez del Pozo J, Marti Herreros M, Simon R, Maties M, Martin Hernandez E, Hennet T, Briones P: Congenital disorder of glycosylation (CDG) type Ie: a new patient. J Inherit Metab Dis 2004;27:591–600.
  9. Hall SE, Rosse WF: The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 1996;87:5332–5340.
  10. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV: Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;333:1253–1258.
  11. Hong Y, Ohishi K, Inoue N, Kang JY, Shime H, Horiguchi Y, van der Goot FG, Sugimoto N, Kinoshita T. Requirement of N-glycan on GPI-anchored proteins for efficient binding of aerolysin but not Clostridium septicum alpha-toxin. EMBO J 2002;21:5047–5056.
  12. Ikezawa H: Glycosylphosphatidylinositol (GPI)-anchored proteins. Biol Pharm Bull 2002;25:409–417.
  13. Kinoshita T, Inoue N: Dissecting and manipulating the pathway for glycosylphos-phatidylinositol-anchor biosynthesis. Curr Opin Chem Biol 2000;4:632–638.
  14. Kinoshita T, Inoue N, Takeda J: Role of phosphatidylinositol-linked proteins in paroxysmal nocturnal hemoglobinuria pathogenesis. Annu Rev Med 1996;47:1–10.
  15. Krauss JS: Laboratory diagnosis of paroxysmal nocturnal hemoglobinuria. Ann Clin Lab Sci 2003;33:401–406.
  16. Lippincott-Schwartz J, Patterson GH: Development and use of fluorescent protein markers in living cells. Science 2003;300:87–91.
  17. Maeda Y, Tanaka S, Hino J, Kangawa K, Kinoshita T: Human dolichol-phosphate-mannose synthase consists of three subunits, DPM1, DPM2 and DPM3. EMBO J 2000;19:2475–2482.
  18. Marquardt T, Denecke J: Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur J Pediatr 2003;162:359–379.
  19. Medof ME, Kinoshita T, Silber R, Nussenzweig V: Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor. Proc Natl Acad Sci USA 1985;82:2980–2984.
  20. Miyata T, Takeda J, Iida Y, Yamada N, Inoue N, Takahashi M, Maeda K, Kitani T, Kinoshita T: The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 1993;259:1318–1320.
  21. Mukhina GL, Buckley JT, Barber JP, Jones RJ, Brodsky RA: Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia. Br J Haematol 2001;115:476–482.
  22. Nakamura N, Inoue N, Watanabe R, Takahashi M, Takeda J, Stevens VL, Kinoshita T: Expression cloning of PIG-L, a candidate N-acetylglucosaminyl-phosphatidylinositol deacetylase. J Biol Chem 1997;272:15834–15840.
  23. Nelson KL, Brodsky RA, Buckley JT: Channels formed by subnanomolar concentrations of the toxin aerolysin trigger apoptosis of T lymphomas. Cell Microbiol 1999;1:69–74.
  24. Rosse WF: Hematopoiesis, the defect in paroxysmal nocturnal hemoglobinuria. J Clin Invest 1997;100:953–954.
  25. Sangiorgio V, Pitto M, Palestini P, Masserini M: GPI-anchored proteins and lipid rafts. Ital J Biochem 2004;53:98–111.
  26. Shin D-J, Lee JJ, Choy HE, Hong Y: Generation and characterization of Clostridium septicum alpha toxin mutants and their use in diagnosing paroxysmal nocturnal hemoglobinuria. Biochem Biophys Res Commun 2004;324:753–760.
  27. Sousa MV, Richardson M, Fontes W, Morhy L: Homology between the seed cytolysin enterolobin and bacterial aerolysins. J Protein Chem 1994;13:659–667.
  28. Tanaka S, Maeda Y, Kinoshita T: Biosynthesis of GPI-anchored proteins. Tanpakushitsu Kakusan Koso 2003;48:990–996.
  29. Tomita S, Inoue N, Maeda Y, Ohishi K, Takeda J, Kinoshita T: A homologue of Saccharomyces cerevisiae Dpm1p is not sufficient for synthesis of dolichol-phosphate-mannose in mammalian cells. J Biol Chem 1998;273:9249–9254.
  30. Yanisch-Perron C, Vieira J, Messing J: Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 1985;33:103–119.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50